News

Filter

Current filters:

None

7880 to 7889 of 96094 results

Takeda's GPR40 agonist for diabetes promising in Ph II trial

28-02-2012

A Phase II trial of Takeda's GPR40 agonist TAK-875 published in The Lancet has found that the drug is…

DiabetesHomepeginesatidePharmaceuticalTAK-875Takeda Pharmaceuticals

GSK boss accuses UK government of blocking new drugs to save money

27-02-2012

The chief executive of the UK’s largest pharmaceutical company, GlaxoSmithKline (LSE: GSK) has accused…

EuropeGlaxoSmithKlineMarkets & MarketingPharmaceuticalPricingRegulation

Greek pharma sector bemoans accumulation of debts

27-02-2012

The Greek pharmaceutical industry association, the SFEE, says that pharmaceutical companies may go out…

EuropeFinancialHealthcarePharmaceuticalPolitics

No proof of added benefit for GlaxoSmithKline’s Trobalt, says IQWiG

27-02-2012

In another warning to drugmakers trying to get approval of new drugs under Germany’s AMNOG reform…

EuropeGlaxoSmithKlineNeurologicalPharmaceuticalPricingRegulationTrobalt

Forest Labs get EU appro for Colobreathe

27-02-2012

US drugmaker Forest Laboratories (NYSE: FRX) said on Friday that the European Medicines Agency has approved…

ColoBreatheColomycinEuropeForest LaboratoriesPharmaceuticalRare diseasesRegulation

Daiichi Sankyo and Terumo link up for vaccine development

27-02-2012

Drug major Daiichi Sankyo (TYO: 4568) and fellow Japanese company Terumo Corp (TYO: 4543) have entered…

Antibiotics and Infectious diseasesDaiichi SankyoPharmaceuticalResearchTerumoVaccines

Future for biosimilars hugely promising, Momenta CEO tells GPhA meeting

26-02-2012

Craig Wheeler, chief executive of Momenta Pharmaceuticals (Nasdaq: MNTA) discussed the promise and prospects…

BiotechnologyGenericsMarkets & MarketingMomenta PharmaceuticalsResearch

Access Pharma’s MuGard OKed in China

26-02-2012

USA-based specialist in supportive care for cancer patients Access Pharmaceuticals (OTCBB: ACCP) revealed…

Access PharmaceuticalsAsia-PacificJain An PharmaceuticalsMuGardOncologyPharmaceuticalRegulationRhei Pharmaceuticals

Merck KGaA sets out efficiency program, with cost and job cuts likely

26-02-2012

Adding to the list of pharma companies announcing significant structural changes and job cuts, on Friday…

FinancialManagementMerck KGaAPharmaceutical

7880 to 7889 of 96094 results

Company Spotlight

ImmunoGen

ImmunoGen

Back to top